Company stability



















Also- if you are looking for stability- perhaps you should look beyond the Pharmaceutical Industy-Let alone a regional cough and cold company trying to go big time.....
 






Also- if you are looking for stability- perhaps you should look beyond the Pharmaceutical Industy-Let alone a regional cough and cold company trying to go big time.....

If RS can't turn a profit for Q2, we will all be looking for jobs when the stock hits below $3 and our top investors pull out. Or we will all be working for Horizon.
 






If RS can't turn a profit for Q2, we will all be looking for jobs when the stock hits below $3 and our top investors pull out. Or we will all be working for Horizon.

RS has put us all at risk. He knew that Trex missing wasnt because of samples. Now we will get our asses kicked when Q2 is just as bad. This place is a joke.
 






RS has put us all at risk. He knew that Trex missing wasnt because of samples. Now we will get our asses kicked when Q2 is just as bad. This place is a joke.

How is this his fault? You said he put us at risk...please explain. Also, I seem to recall that April numbers for trex were just over 100% to goal nationally. Lastly, the weekly national rx count improved in May vs April and has been climbing more in June, so it's worth arguing that we will be well over 100% to goal for trex in Q2.
 






How is this his fault? You said he put us at risk...please explain. Also, I seem to recall that April numbers for trex were just over 100% to goal nationally. Lastly, the weekly national rx count improved in May vs April and has been climbing more in June, so it's worth arguing that we will be well over 100% to goal for trex in Q2.

If they report another loss the stock will take a nose dive. Someone has to take the blame and it will not be DD. JJ is too new to point fingers at. Board will demand quick changes if stock gets to $3-4
 






If they report another loss the stock will take a nose dive. Someone has to take the blame and it will not be DD. JJ is too new to point fingers at. Board will demand quick changes if stock gets to $3-4

Thats exactly my point. Trex sales werenot 100%, but more important was the message to investors regarding the shortfall. Q2 will look just like Q1, maybe slightly higher, but nowhere near GSK numbers. The expectations were made by RS and we will pay for those expectations.
 






Is this a stable company to work for? I can't go through getting downsized again.

Any company is as stable as its pipeline and sales force. Old products. Rehashed. Get busy. Earn your keep. RS is from several rehash mixes. Not sure if any have been directly successful due to his efforts but the teams were top notch. Make this work as pharma is quickly disappearing as we know it.